NDC properties for "Revlimid 2.5 MG Oral Capsule" (RxCUI 1242233)
About this data
The tables show NDC propoerties for Revlimid 2.5 MG Oral Capsule with the RxCUI 1242233
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Revlimid 2.5 MG Oral Capsule (RxCUI 1242233)
| MMSL_CODE | BD27635 |
|---|---|
| NDA | NDA021880 |
| RxCUI | 1242233 |
| SPL_SET_ID | 5fa97bf5-28a2-48f1-8955-f56012d296be |
| Prescribable Synonym | Revlimid 2.5 MG Oral Capsule |
| RXNAV_STR | Revlimid 2.5 MG Oral Capsule |
| RxNorm Name | lenalidomide 2.5 MG Oral Capsule [Revlimid] |
| RxNorm Synonym | Revlimid 2.5 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 1242233) |
NDC Properties
NDC Item 59572040200
| NDC 9 | 59572-402 |
|---|---|
| NDC 10 | 59572-402-00 |
| NDC Item | 59572040200 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-402-00) |
| COLORTEXT | GREEN,WHITE |
| Color | C48329;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;2;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2012-04-16 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 59572-402 |
NDC Item 59572040228
| NDC 9 | 59572-402 |
|---|---|
| NDC 10 | 59572-402-28 |
| NDC Item | 59572040228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59572-402-28) |
| COLORTEXT | GREEN,WHITE |
| Color | C48329;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;2;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2012-04-16 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 59572-402 |
NDC Item 59572040200
| NDC 9 | 59572-402 |
|---|---|
| NDC 10 | 59572-402-00 |
| NDC Item | 59572040200 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-402-00) |
| COLORTEXT | GREEN,WHITE |
| Color | C48329;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;2;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2012-04-16 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 59572-402 |
NDC Item 59572040228
| NDC 9 | 59572-402 |
|---|---|
| NDC 10 | 59572-402-28 |
| NDC Item | 59572040228 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59572-402-28) |
| COLORTEXT | GREEN,WHITE |
| Color | C48329;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;2;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2012-04-16 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 59572-402 |